Accendra Health, Inc. (ACH)
NYSE • Healthcare
Last close at September 16, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Accendra Health, Inc. currently loses $15.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 29
in 43 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Accendra Health, Inc. said based on preliminary second fiscal quarter of 2026 results on Aug. 10 that revenue of about $613.2 million missed the $628.7 million estimate by 2.5% and fell ~10% from $681.9 million a year ago. Gross profit came in at about $263.4 million, with gross margin near 43%. Net income was a loss of about $89.1 million, improving 89.8% from a loss of $869.1 million a year earlier. Operating cash flow was $50.1 million.
About Accendra Health, Inc.
Accendra Health, Inc. (NYSE: ACH) operates in healthcare distribution and related services, supplying providers and manufacturers with medical and surgical supplies while also running home-based patient-care operations. In FY2025, the company recorded $2.8 billion in revenue. Formerly known as Owens & Minor, Inc., it is based in Glen Allen, Virginia.
Today's Snapshot
ACH closed 2.7% lower on heavier trading than usual.
Trading Volume
Above 10d avg 857.2K
1.1M
vs S&P 500 Today
Underperforming Market
-2.12%
Updated: September 16, 2026 at 20:13 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$1.13 - $2.69Sell
- RSI (14)30.40Neutral
- Stochastic %K (14, 3, 3)47.76Neutral
- MACD Level (12, 26)-0.26Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.